Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for ICLR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 18.83%
March 31, 2026 19.06%
December 31, 2025 18.48%
September 30, 2025 21.42%
June 30, 2025 23.82%
March 31, 2025 23.12%
December 31, 2024 26.00%
September 30, 2024 25.25%
June 30, 2024 19.79%
March 31, 2024 20.89%
December 31, 2023 22.78%
September 30, 2023 22.38%
June 30, 2023 22.06%
March 31, 2023 22.13%
December 31, 2022 22.38%
September 30, 2022 21.87%
June 30, 2022 20.62%
March 31, 2022 20.08%
December 31, 2021 20.59%
September 30, 2021 19.71%
June 30, 2021 25.57%
March 31, 2021 25.00%
December 31, 2020 27.33%
September 30, 2020 27.29%
June 30, 2020 25.56%
Date Value
March 31, 2020 27.06%
December 31, 2019 27.78%
September 30, 2019 27.52%
June 30, 2019 27.23%
March 31, 2019 27.24%
December 31, 2018 27.23%
September 30, 2018 27.29%
June 30, 2018 27.33%
March 31, 2018 27.84%
December 31, 2017 37.75%
September 30, 2017 37.33%
June 30, 2017 38.65%
March 31, 2017 38.67%
December 31, 2016 38.65%
September 30, 2016 38.65%
June 30, 2016 38.52%
March 31, 2016 39.15%
December 31, 2015 39.38%
September 30, 2015 38.97%
June 30, 2015 38.45%
March 31, 2015 37.67%
December 31, 2014 37.39%
September 30, 2014 37.12%
June 30, 2014 36.14%
March 31, 2014 34.88%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
IQVIA Holdings, Inc. 26.20%
Medpace Holdings, Inc. 27.56%
Proteome Sciences Plc --
Champions Oncology, Inc. 48.77%
Avantor, Inc. 31.73%